Depreciation in USD of Grace Therapeutics, Inc. from 2018 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Grace Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2018 to Q2 2025.
  • Grace Therapeutics, Inc. Depreciation for the quarter ending June 30, 2025 was $2K, a 100% increase year-over-year.
  • Grace Therapeutics, Inc. annual Depreciation for 2024 was $7K, a 36.4% decline from 2023.
  • Grace Therapeutics, Inc. annual Depreciation for 2023 was $11K, a 91.1% decline from 2022.
  • Grace Therapeutics, Inc. annual Depreciation for 2022 was $124K.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Grace Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $2K +$1K +100% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q2 2024 $1K -$6K -85.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q2 2023 $7K -$160K -95.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q2 2022 $167K $167K +$167K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $0 $0 -$1K -100% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-23
Q4 2021 $1K $0 $0 Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $1K $0 -$56K -100% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $57K $0 -$86K -100% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $143K $1K -$409K -99.8% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-21
Q4 2020 $552K $0 -$110K -100% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $662K $56K -$16K -22.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $678K $86K -$3K -3.37% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $681K $410K +$26K +6.77% Jan 1, 2020 Mar 31, 2020 10-K 2020-06-29
Q4 2019 $655K $110K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $72K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $89K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $384K Jan 1, 2019 Mar 31, 2019 10-K 2020-06-29

Grace Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $7K -$4K -36.4% Apr 1, 2024 Mar 31, 2025 10-K 2025-06-23
2023 $11K -$113K -91.1% Apr 1, 2023 Mar 31, 2024 10-K 2025-06-23
2022 $124K +$124K Apr 1, 2022 Mar 31, 2023 10-K 2024-06-21
2021 $0 -$143K -100% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-23
2020 $143K -$267K -65.1% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-21
2019 $410K +$26K +6.77% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-22
2018 $384K Apr 1, 2018 Mar 31, 2019 10-K 2020-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.